Seegene, Stock Price +8.92% at This Hour... 201,000 Shares Net Sold by Individuals in Last 5 Days
As of 2:31 PM on the 8th, Seegene is trading at 144,100 KRW, up 8.92% from the previous day. The trading volume is 8,520,091 shares, which is 150.17% of the previous day's volume. Seegene is known as a developer, manufacturer, and seller of molecular diagnostic reagents.
On July 8th, Hana Financial Investment researcher Minjeong Seon reported, "In the case of the GH type virus mutation, it has been reported that the transmissibility has increased sixfold compared to the existing virus. It is expected that it will take more than three years for vaccine and therapeutic development to be completed due to this mutation. The COVID-19 pandemic is not a one-time event but a long-term event lasting more than three years. There is a need to re-rate Seegene's valuation." She set Seegene's target price at 200,000 KRW.
Over the past five days, individual investors have net sold 201,000 shares of Seegene, while foreigners and institutions have net bought 188,013 shares and 51,850 shares, respectively.

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- Jensen Huang: "China Will Eventually Allow Imports of U.S. AI Chips"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.